Benzinga -
- Morgan Stanley (NYSE:MS) cut VTEX (NYSE: VTEX) price target from $7 to $5. Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on Friday.
- Keybanc cut Progyny, Inc. (NASDAQ: PGNY) price target from $55 to $45. Keybanc analyst Scott Schoenhaus maintained an Overweight rating on the stock. Progyny gained 4.1% to close at $31.83 on Friday.
- SVB Leerink raised the price target on Roivant Sciences Ltd. (NASDAQ: ROIV) from $8 to $10. SVB Leerink analyst David Risinger maintained an Outperform rating on the stock. Roivant Sciences shares gained 1.1% to close at $7.32 on Friday.
- Raymond James boosted W. P. Carey Inc. (NYSE: WPC) price target from $80 to $85. Raymond James analyst RJ Milligan maintained an Outperform rating on the stock. W. P. Carey shares fell 0.1% to $79.73 in pre-market trading.
- Needham raised AtriCure, Inc. (NASDAQ: ATRC) price target from $55 to $58.. Needham analyst Mike Matson maintained a Buy rating on the stock. AtriCure shares fell 2.6% to close at $41.37 on Friday.
- JP Morgan cut Glaukos Corporation (NYSE: GKOS) price target from $48 to $42. JP Morgan analyst Allen Gong upgraded the stock from Underweight to Neutral. Glaukos shares rose 0.8% to $42.83 in pre-market trading.
- Jefferies raised Moderna (NASDAQ:MRNA), Inc. (NASDAQ: MRNA) price target from $170 to $275. Jefferies analyst Michael Yee upgraded the stock from Hold to Buy. Moderna shares fell 6.7% to close at $193.29 on Friday.
- Stifel boosted Xylem Inc. (NYSE: NYSE:XYL) price target from $113 to $115. 170. Stifel analyst Nathan Jones downgraded the stock from Buy to Hold. Xylem shares fell 0.6% to $109.27 in pre-market trading.
- Piper Sandler raised ConocoPhillips (NYSE: NYSE:COP) price target from $155 to $157. Piper Sandler analyst Ryan Todd maintained an Overweight rating on the stock. ConocoPhillips shares rose 1% to $111.50 in pre-market trading.
- HC Wainwright & Co. boosted Astria Therapeutics, Inc. (NASDAQ: ATXS) price target from $13 to $20. HC Wainwright & Co. analyst Joseph Pantginis maintained the stock with a Buy rating. Astria Therapeutics shares jumped 4.8% to close at $11.81 on Friday.
- Baird cut L3Harris Technologies, Inc. (NYSE: LHX) price target from $290 to $241. Baird analyst Peter Arment downgraded the stock from Outperform to Neutral. L3Harris Technologies shares fell 1.5% to $210.00 in pre-market trading.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.